Cambrex corporation announced plans to expand its facility in Edinburgh, Scotland, doubling the current footprint to 15,000 square feet.
Currently, Cambrex's Edinburgh facility provides solid form development services, including investigations such as salt, co-crystal and polymorph screening, as well as crystallisation process development and GMP analytical services.
The additional instruments and reactors for large-scale crystallisation studies and solid form screening capabilities will be the new features of the expanded facility.
Additionally, the company plans to install Ultra-Performance Liquid Chromatography (UPLC) and gas chromatography instruments, as well as additional Process Analytical Technology (PAT) tools.
The project is expected to be completed by the end of the year.